Bacteriophages as Therapeutic and Diagnostic Vehicles in Cancer
Evolution of nanomedicine is the re-design of synthetic and biological carriers to implement novel theranostic platforms. In recent years, bacteriophage research favors this process, which has opened up new roads in drug and gene delivery studies. By displaying antibodies, peptides, or proteins on t...
Main Authors: | Valentina Foglizzo, Serena Marchiò |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-02-01
|
Series: | Pharmaceuticals |
Subjects: | |
Online Access: | https://www.mdpi.com/1424-8247/14/2/161 |
Similar Items
-
Progress on Phage Display Technology: Tailoring Antibodies for Cancer Immunotherapy
by: Renato Kaylan Alves França, et al.
Published: (2023-09-01) -
Native llama Nanobody Library Panning Performed by Phage and Yeast Display Provides Binders Suitable for C-Reactive Protein Detection
by: Sandra Oloketuyi, et al.
Published: (2021-12-01) -
Application of Next Generation Sequencing (NGS) in Phage Displayed Peptide Selection to Support the Identification of Arsenic-Binding Motifs
by: Robert Braun, et al.
Published: (2020-11-01) -
MimoDB: a New Repository for Mimotope Data Derived from Phage Display Technology
by: Xianlong Wang, et al.
Published: (2010-11-01) -
Phage-Display Based Discovery and Characterization of Peptide Ligands against WDR5
by: Jiawen Cao, et al.
Published: (2021-02-01)